Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML

Clinical trial NCT01690065 · UNKNOWN

Trial details

NCT number: NCT01690065
Sponsor: Ulsan University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia in Myeloid Blast Crisis Untreated Adult Acute Myeloid Leukemia

Start date: 2012-09-01
Primary completion: 2019-09-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.